Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours.

Cancer Med · 2021 · PMC8633256 · PMID 34697905

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

13 We identified one patient with a clinically significant change in IGF1 levels in the PRRT group (with confirmed GH deficiency on glucagon stimulation testing), and on looking at patient z ‐scores these showed a possible trend for being lower in the PRRT group.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.